In Vivo Cytokine Gene Expression in Various T Cell Subsets of the Autoimmune MRL/Mp-lpr/lpr Mouse

References

• Morse HC, Davidson WF, Yetter RA, Murphy ED, Roth JB, Coffman RF. Abnormalities induced by the mutant gene lpr: expression of a unique lymphocyte subset. J Immunol 1982; 129: 2612–2615
   PubMed Web of Science ®Google Scholar
• Theofilopoulos AN, Dixon FJ. Murine modes of systemic lupus erythematosus. Adv Immunol 1985; 37: 269–390
   PubMed Web of Science ®Google Scholar
• Berden JH. L., Hang L, McConahey PJ, Dixon FJ. Analysis of vascular lesions in murine SLE. I. Association with serologic abnormalities. J Immunol 1983; 130: 1699–1705
   PubMed Web of Science ®Google Scholar
• Stafford-Brady F, Sugiyama E, Robinson DR, Sy M-S, Bonventre JV, Yeh ETH. Defective signal transduction in CD4-CD8-T cells of lpr mice. Cell Immunol 1989; 123: 396–404
   PubMed Web of Science ®Google Scholar
• Katagiri K. T., Katagiri T, Eisenberger RA, Ting J, Cohen PL. Interleukin 2 responses of lpr and normal L3T4-/ Lyt-2″ T cells induced by TPA plus A23187. J Immunol 1987; 138: 149–156
   PubMed Web of Science ®Google Scholar
• Kim C, Kiminovitch KA, Ochi A. 1991. Reduction of lupus nephritis in MRL/lpr mice by a bacterial superantigen treatment. J Exp Med 1991; 174: 1431–1437
   PubMed Web of Science ®Google Scholar
• Cohen PL, Rapoport R, Eisenberg RA. Characterization of functional T-cell lines derived from MRL mice. Clin Immunol Immunopathol 1986; 40: 485–496
   Google Scholar
• Weston KM, Ju St Lu CY, Sy MS. Autoreactive T cells in MRL/MP-lpr/lpr mice. Characterization of the lym-phokines produced and analysis of antigen-presenting cells required. J Immunol 1988; 141: 1941–1948
   PubMed Web of Science ®Google Scholar
• Masinovsky B, Uradal D, Gallantin WM. IL-4 acts synergis-tically with IL-1 p to promote lymphocyte adhesion to microvascular endothelium by induction of vascular adhesion molecule-1. J Immunol 1990; 145: 2886–2895
   PubMed Web of Science ®Google Scholar
• Oppenheimer-Marks N, David LS, Lipsky DE. Human T lymphocyte adhesion to endothelial cells and transendothelial migration. Alteration of receptor use relates to the activation status of both the T cells and the endothelial cell. J Immunol 1990; 145: 140–148
   PubMed Web of Science ®Google Scholar
• Chin Y-H, Cai J-P, Johson K. Lymphocyte adhesion to cultured peyer's path high endothelial venule cells is mediated by organ specific homing receptors and can be regulated by cytokines. J Immunol 1990; 145: 3669–3677
   PubMed Web of Science ®Google Scholar
• Boswell J M, Yui MA, Endres S, Burt DW, Kelly VE. Novel and enhanced IL-1 gene expression in autoimmune mice with lupus. J Immunol 1988; 141: 118–124
   PubMed Web of Science ®Google Scholar
• Tang B, Matsuda T, Akira S, Nagata N, Ikiharam S, Hirano S., Kishimoto T. Age-associated increase in interleukin 6 in MRL/lpr mice. Int Immunol 1991; 3: 273–278
   PubMed Web of Science ®Google Scholar
• Alvaro-Gracia JM, Zvaifler J, Brown CB, Kaushansky K, Firestein GS. Cytokines in chronic inflammatory arthritis. VI. Analysis of the synovial cells involved in granulocyte-macrophage colony-stimulating factor production and gene expression in rheumatoid arthritis and its regulation by IL-1 and tumor necrosis factor-a. J Immunol 1991; 146: 3365–3371
   PubMed Web of Science ®Google Scholar
• Jacob CO. Tumor necrosis factor a in autoimmunity: pretty girl or old witch. Immunol Today 1992; 13: 122–125
   PubMedGoogle Scholar
• Lampe MA, Patarca R, Iregui MV, Cantor H. Polyclonal B cell activation by the eta-1 cytokine and the development of systemic autoimmune disease. J Immunol 1991; 147: 2902–1906
   PubMedGoogle Scholar
• Dialynas DP, Wilde DB, Marrack P, Pierres A, Wall KA, Havran W, Otten G, Loken MR, Pierres M, Kappler J, Fitch FW. Characterization of the murine antigenic determinant, designated L3T4a, recognized by monoclonal antibody GK1.5: expression of L3T4a by functional T cell clones appears to correlate primarily with class II MHC antigen-reactivity. Immunol Rev 1983; 74: 29–56
   PubMed Web of Science ®Google Scholar
• Ledbetter JA, Herzenberg LA. Xenogeneic antibodies to mouse lymphoid differentiation antigens. Immunol Rev 1979; 47: 63–90
   PubMed Web of Science ®Google Scholar
• Coffman RL, Weissman IL. B220: a B cell specific member oftheT200 glycoprotein family. Nature 1981; 289: 681–683
   PubMed Web of Science ®Google Scholar
• Chmomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 1987; 162: 156–159
   Google Scholar
• Murray LJ, Lee R, Martens C. In vivo cytokine gene expression in T cell subsets of the autoimmune MRL/Mp-lpr/ lpr mouse. Eur J Immunol 1990; 20: 163–170
   PubMed Web of Science ®Google Scholar
• Namen AE, Lupton S, Hjerrild K, Wignall J, Mochizuki DY, Schmierer A, Mosley B., March CJ, Urdal D, Gillis S, Cosman D, Goodwin RG. Stimulation of B-cell progenitors by cloned murine interleukin-7. Nature 1988; 333: 571–573
   PubMed Web of Science ®Google Scholar
• Moore KW, Vieira P, Fiorentino DF, Trounstine ML, Khan TA, Mosman TR. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRF1. Science 1990; 248: 1230–1234
   PubMed Web of Science ®Google Scholar
• Geiser AG, Kim SJ, Rober AB, Sporn MB. Characterization of the mouse transforming growth factor-beta-1 promoter and activation by the Ha-ras oncogene. Mol Cell Biol 1991; 11: 84–92
   PubMed Web of Science ®Google Scholar
• Pytela R. Amino acid sequence of the murine Mac-1 alpha chain reveals homology with the integrin family and an additional domain related to von Willebrand factor. EMBO J 1988; 7: 1371–1378
   PubMed Web of Science ®Google Scholar
• Patarca R, Freeman GJ, Singh RP, Wei F-Y, Durfee T, Blattner F, Regnier DC, Kozak CA, Mock BA, Morse HC, Jerrelis TR, Cantor H. Structural and functional studies of the early T lymphocyte activation 1 (Eta-1) gene. J Exp Med 1989; 170: 145–161
   PubMed Web of Science ®Google Scholar
• Thomas ML, Reynolds PJ, Chain A, Ben-Neriah Y, Trowbridge IS. B cell variant of mouse T200 (Lyt-5): Evidence for alternative mRNA splicing. Proc Natl Acad Sci USA 1987; 84: 5360–5363
   PubMedGoogle Scholar
• Bottazo GF, Todd I, Mirakian R, Belflore A, Pujol-Borrell R. Organ-specific autoimmunity; a 1986 overview. Immunol Rev 1986; 94: 137–169
   Google Scholar
• Schmit DS, Horneeng R, McGrath KM, Paul N, Ruddle NH. Target cell DNA fragmentation is mediated by lym-photoxin and tumor-necrosis factor. Lymphokine Res 1987; 6: 195–202
   Google Scholar
• Kishimoto T, Hirano T. Molecular regulation of B lymphocyte response. Ann Rev Immunol 1988; 6: 485–512
   PubMed Web of Science ®Google Scholar
• Prud'homme GJ, Park CL, Fieser TM, Kofler R, Dixon FJ, Theofilopoulos AN. Identification of a B cell differentiation factors) spontaneously produced by proliferating T cells in murine lupus strains of the lpr/lpr genotype. J Exp Med 1983; 157: 730–742
   PubMed Web of Science ®Google Scholar
• Prud'homme GJ, Fieser TM, Dixon FJ, Theofilopoulos AN. B cell-tropic interleukins in murine systemic lupus erythematosus (SLE). Immunol Rev 1984; 78: 159–183
   Google Scholar
• Davidson WF, Calkins C, Hugin A, Giese T, Holmes KL. Cytokine secretion by C3H-lpr and -gld T cells. Hypersecretion of IFN-y and tumor necrosis factor-a by stimulated CD4 + T cells. J Immunol 1991; 146: 4138–4148
   PubMed Web of Science ®Google Scholar
• Palacios R. Spontaneous production of interleukin 3 by T lymphocytes from autoimmune MRL/MP-lpr/lpr mice. Eur J Immunol 1984; 14: 599–605
   PubMed Web of Science ®Google Scholar
• Kelley VE, Farber NM, Williams JM, Strom TB. Inability of autoimmune mice with the lpr gene to spontaneously produce interleukin 3. Eur J Immunol 1986; 16: 464–467
   Google Scholar
• MacNeil D, Krystal G, Fairhurst M, Waterfield JD. Correction of defective IL-3 responses of T lymphocytes from autoimmune mice. J Immunol 1986; 137: 3464–3468
   PubMedGoogle Scholar
• Patarca R, Wei F-Y, Singh P, Morasso MI, Cantor H. Dysregulated expression of the T cell cytokine Eta-1 in CD4-CD8-lymphocytes during the development of murine autoimmune disease. J Exp Med 1990; 172: 1177–1183
   PubMed Web of Science ®Google Scholar
• Kovacs EJ. Fibrogenic cytokines: the role of immune mediators in the development of scar tissue. Immunol Today 1991; 12: 17–23
   PubMedGoogle Scholar